Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Enanta Pharmaceuticals Inc?

Accepted Answer

Según el último estado financiero (Form-10K), Enanta Pharmaceuticals Inc tiene un total de activos de $376, una ganancia neta loss de $-116

Question 2

¿Cuáles son los ratios financieros clave para ENTA?

Accepted Answer

El ratio corriente de Enanta Pharmaceuticals Inc es 1.52, el margen neto es -173.13, las ventas por acción son $3.16.

Question 3

¿Cómo se desglosan los ingresos de Enanta Pharmaceuticals Inc por segmento o geografía?

Accepted Answer

Enanta Pharmaceuticals Inc largest revenue segment is Small Molecule Drugs, at a revenue of 67,635,000 in the most earnings release.For geography, United States is the primary market for Enanta Pharmaceuticals Inc, at a revenue of 67,635,000.

Question 4

¿Es rentable Enanta Pharmaceuticals Inc?

Accepted Answer

no, según los últimos estados financieros, Enanta Pharmaceuticals Inc tiene una ganancia neta loss de $-116

Question 5

¿Tiene Enanta Pharmaceuticals Inc alguna deuda?

Accepted Answer

yes, Enanta Pharmaceuticals Inc tiene una deuda de 247

Question 6

¿Cuántas acciones en circulación tiene Enanta Pharmaceuticals Inc?

Accepted Answer

Enanta Pharmaceuticals Inc tiene un total de acciones en circulación de 21.19

Breakdown	TTM	09/30/2024	09/30/2023	09/30/2022	09/30/2021	09/30/2020
Revenue	64	67	79	86	97	122
Revenue Growth (YoY)	-10%	-15%	-8%	-11%	-20%	-40%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	47	57	52	45	32	27
Research & Development	113	131	163	164	174	136
Operating Expenses	161	189	216	210	206	164
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-94	-117	-131	-122	-107	-35
Income Tax Expense	-2	-1	2	0	-28	1
Net Income	-92	-116	-133	-121	-79	-36
Net Income Growth	-20%	-13%	10%	53%	119%	-178%
Shares Outstanding (Diluted)	21.37	21.15	21	20.6	20.2	19.9
Shares Change (YoY)	1%	1%	2%	2%	2%	-5%
EPS (Diluted)	-4.32	-5.48	-6.38	-5.91	-3.92	-1.81
EPS Growth	-21%	-14%	8%	51%	117%	-182%
Free Cash Flow	-43	-96	-112	-86	-70	5
Free Cash Flow Per Share	-2.01	-4.53	-5.33	-4.17	-3.46	0.25
Gross Margin	--	--	--	--	--	--
Operating Margin	-150%	-180.59%	-173.41%	-143.02%	-112.37%	-33.6%
Profit Margin	-143.75%	-173.13%	-168.35%	-140.69%	-81.44%	-29.5%
Free Cash Flow Margin	-67.18%	-143.28%	-141.77%	-100%	-72.16%	4.09%
EBITDA	-93	-119	-135	-121	-106	-38
EBITDA Margin	-145.31%	-177.61%	-170.88%	-140.69%	-109.27%	-31.14%
D&A For EBITDA	3	2	2	2	3	3
EBIT	-96	-121	-137	-123	-109	-41
EBIT Margin	-150%	-180.59%	-173.41%	-143.02%	-112.37%	-33.6%
Effective Tax Rate	2.12%	0.85%	-1.52%	0%	26.16%	-2.85%

Enanta Pharmaceuticals Inc (ENTA) Price

ENTA Stock Price Chart

ENTA Income

Follow-Up Questions